{
  "ticker": "INCY",
  "company_name": "Incyte Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03679767",
      "title": "A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Metastatic Non-small Cell Lung Cancer, Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer, Unresectable Melanoma, Metastatic Melanoma, Locally Advanced Renal Cell Carcinoma, Metastatic Clear-Cell Renal Cell Carcinoma",
      "start_date": "2019-01-09",
      "completion_date": "2022-06-28",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT06548360",
      "title": "A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "NonSegmental Vitiligo",
      "start_date": "2025-01-24",
      "completion_date": "2027-03-13",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT04070781",
      "title": "Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Steroid Refractory GVHD, Graft Vs Host Disease",
      "start_date": "2020-01-20",
      "completion_date": "2021-12-13",
      "enrollment": 0,
      "sponsor": "Columbia University"
    },
    {
      "nct_id": "NCT00398619",
      "title": "A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Insulin Resistance, Obesity",
      "start_date": "2006-11",
      "completion_date": "2007-03",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT00864175",
      "title": "Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Breast Cancer",
      "start_date": "2007-07",
      "completion_date": "2011-10",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT04659616",
      "title": "Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Acute Myeloid Leukemia",
      "start_date": "2021-01-14",
      "completion_date": "2026-12-31",
      "enrollment": 0,
      "sponsor": "OHSU Knight Cancer Institute"
    },
    {
      "nct_id": "NCT03569371",
      "title": "A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hidradenitis Suppurativa",
      "start_date": "2018-07-17",
      "completion_date": "2019-04-22",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT03906344",
      "title": "Expanded Access Use of INCB052793 to Treat a Single Patient With Myelofibrosis",
      "status": "NO_LONGER_AVAILABLE",
      "phase": "",
      "condition": "",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT06310304",
      "title": "A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Participants",
      "start_date": "2024-03-26",
      "completion_date": "2024-05-15",
      "enrollment": 0,
      "sponsor": "Incyte Corporation"
    },
    {
      "nct_id": "NCT03182894",
      "title": "Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer",
      "status": "WITHDRAWN",
      "phase": "PHASE1, PHASE2",
      "condition": "Metastatic Colorectal Cancer",
      "start_date": "2018-09-30",
      "completion_date": "2020-07-30",
      "enrollment": 0,
      "sponsor": "James J Lee"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE2": 16,
      "PHASE3": 6,
      "PHASE1": 15,
      "PHASE1, PHASE2": 10,
      "": 1,
      "PHASE2, PHASE3": 1,
      "EARLY_PHASE1": 1
    },
    "by_status": {
      "COMPLETED": 25,
      "RECRUITING": 12,
      "TERMINATED": 6,
      "NO_LONGER_AVAILABLE": 1,
      "WITHDRAWN": 1,
      "ACTIVE_NOT_RECRUITING": 4,
      "NOT_YET_RECRUITING": 1
    },
    "active_trials": 16,
    "completed_trials": 25,
    "conditions": [
      "Acute Graft-versus-host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects",
      "Acute Myeloid Leukemia",
      "Advanced Malignancies, Metastatic Cancer",
      "Atopic Dermatitis",
      "Breast Cancer",
      "CNS Lymphoma, Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma",
      "Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Esophageal Cancer, Hepatocellular Carcinoma, Melanoma (Uveal Melanoma Excluded), Merkel Cell Carcinoma, Mesothelioma, MSI-high Colorectal Cancer, Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Small Cell Lung Cancer (SCLC), Renal Cell Carcinoma (RCC), Triple-negative Breast Cancer, Urothelial Carcinoma, Diffuse Large B-cell Lymphoma",
      "Chronic Graft Versus Host Disease",
      "Chronic Graft-versus-host-disease",
      "Chronic Myelomonocytic Leukemia, Leukemia",
      "Diffuse Large B-Cell Lymphoma",
      "Diffuse Large B-cell Lymphoma",
      "Exanthema, Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy",
      "Fibrodysplasia Ossificans Progressiva (FOP)",
      "Glioblastoma",
      "Healthy Participants",
      "Hidradenitis Suppurativa",
      "Hidradenitis Suppurativa (HS)",
      "Insulin Resistance, Obesity",
      "Lymphoma",
      "Melanoma",
      "Metastatic Colorectal Cancer",
      "Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Advanced Myxoid Liposarcoma, Advanced Soft Tissue Sarcoma, Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Soft Tissue Sarcoma, Refractory Leiomyosarcoma, Refractory Myxoid Liposarcoma, Refractory Round Cell Liposarcoma, Refractory Soft Tissue Sarcoma, Refractory Synovial Sarcoma, Refractory Undifferentiated Pleomorphic Sarcoma, Advanced Leiomyosarcoma, Advanced Synovial Sarcoma, Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Chondrosarcoma",
      "Metastatic Non-small Cell Lung Cancer, Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer, Unresectable Melanoma, Metastatic Melanoma, Locally Advanced Renal Cell Carcinoma, Metastatic Clear-Cell Renal Cell Carcinoma",
      "Myelofibrosis",
      "Myeloproliferative Neoplasms",
      "Non Small Cell Lung Carcinoma, Renal Cell Carcinoma",
      "Non-segmental Vitiligo",
      "NonSegmental Vitiligo",
      "Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer, Castration Resistant Prostate Cancer, Colorectal Cancer, Gastric/ Gastroesophageal Junction, Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Squamous Carcinoma of the Anal Canal",
      "Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis",
      "Prurigo",
      "Prurigo Nodularis",
      "Psoriasis",
      "Rectal Cancer",
      "Seborrheic Dermatitis",
      "Solid Tumors",
      "Solid Tumors and Hematologic Malignancy",
      "Solid Tumors, Advanced Malignancies, Metastatic Cancer",
      "Stage IV Non-small Cell Lung Cancer, Cachexia",
      "Steroid Refractory GVHD, Graft Vs Host Disease"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:05.379048",
    "search_query": "Incyte Corporation",
    "url": "https://clinicaltrials.gov/search?term=Incyte+Corporation"
  }
}